House Dem chairmen to meet with progressives amid drug pricing divisions

House Dem chairmen to meet with progressives amid drug pricing divisions
© Greg Nash

Two key House Democratic committee chairmen will meet with progressive House Democrats next week amid divisions in the party over how to craft their signature legislation to lower drug prices, according to House Democratic aides.

House Energy and Commerce Committee Chairman Frank Pallone Jr.Frank Joseph PalloneMcConnell, Kaine introduce bill to raise tobacco purchasing age from 18 to 21 The Hill's Morning Report - Presented by Pass USMCA Coalition - Restrictive state abortion laws ignite fiery 2020 debate Work on surprise medical bills goes into overdrive MORE (D-N.J.) and House Ways and Means Committee Chairman Richard NealRichard Edmund NealDemocrats sense new momentum in Trump tax return fight IRS draft memo found that agency must provide tax returns to Congress: report Senate passes bill to undo tax increase on Gold Star military families MORE (D-Mass.) will meet with members of the Congressional Progressive Caucus next week to discuss legislation to allow Medicare to negotiate drug prices.

Lawmakers in the Progressive Caucus have been pushing for what they view as a bill that is tougher on drug companies, from Rep. Lloyd DoggettLloyd Alton DoggettTreasury Department rejects Dem subpoena for Trump tax returns On The Money: New tariffs on China pose major risk for Trump | Senators sound alarm over looming budget battles | Ocasio-Cortez, Sanders team up against payday lenders Dems highlight NYT article on Trump's business losses in 'tax gap' hearing MORE (D-Texas), which would strip a company of its monopoly on a drug if it refused to negotiate the price with the government.

But Speaker Nancy PelosiNancy Patricia D'Alesandro PelosiTrump rips Dems' demands, impeachment talk: 'Witch Hunt continues!' The Hill's Morning Report - Pelosi remains firm despite new impeachment push The Memo: Trump allies see impeachment push backfiring on Democrats MORE’s (D-Calif.) office is working on a competing plan that would use an outside arbitrator to set the price if negotiations fell through, a system that some progressives view as too weak.

The meeting could allow the powerful chairmen to discuss the differences of opinion on drafting the legislation with the progressive lawmakers.

A House Democratic aide said the chairmen would not be presenting a plan at the meeting and instead would be listening to gather input from lawmakers about how to craft legislation for Medicare to negotiate drug prices.

Lowering drug prices is one of House Democrats’ top priorities, one that Pelosi frequently touts as part of the party’s focus on kitchen table issues. But Democrats have yet to unveil their signature legislation on the topic, leading some progressives to grow impatient about the pace of action on a core priority.

Complicating the situation, Pelosi’s office is also in talks with the White House about lowering drug prices, something that some progressives also view with skepticism.

Pelosi expressed optimism about reaching a deal with President TrumpDonald John TrumpTrump rips Dems' demands, impeachment talk: 'Witch Hunt continues!' Nevada Senate passes bill that would give Electoral College votes to winner of national popular vote The Hill's Morning Report - Pelosi remains firm despite new impeachment push MORE on lowering drug prices in an interview with Time magazine on Tuesday.

“In our conversations, [at a] staff level, and my conversations with him I think we can find a path do that,” Pelosi said.